Ceres Nanosciences
Latest round
- Series A
Last raised
- Feb 2017
Total raised
- $3M
Investors
- 1
About Ceres Nanosciences
Ceres Nanosciences, Inc.Ceres Nanosciences, Inc. specializes in advanced nanotechnology solutions, founded in 2008 and headquartered in Manassas, US. The company has pivoted to prioritize precision analytics and liquid biopsy technologies. The CEO is Ross Dunlap, who has experience in leading tech initiatives.Ceres Nanosciences offers specialized products such as Nanotrap Microbiome Particles, the NEAT Liquid Biopsy Kit, and the Nanotrap Protein Enrichment Affinity Kit.Ceres Nanosciences generates revenue through direct B2B sales of its products, including the Nanotrap Microbiome Particles and NEAT Liquid Biopsy Kit.2 mn Grant from April 2021 to develop and implement wastewater-based surveillance systems for COVID-19, leveraging their Nanotrap® particle technology to cater to underserved populations. The company is also targeting expansion into new geographic areas to enhance service delivery and increase its market presence.
Who invested in Ceres Nanosciences
1 investor across 1 round
See all investors in Ceres Nanosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 2, 2017
Amount
$3M
Investors
Questions about Ceres Nanosciences
Who invested in Ceres Nanosciences?
Ceres Nanosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ceres Nanosciences raised?
Ceres Nanosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ceres Nanosciences last raise money?
Ceres Nanosciences's most recent round on record is a Series A, in Feb 2017.
What does Ceres Nanosciences do?
Ceres Nanosciences is a biotechnology company.
Where is Ceres Nanosciences headquartered?
Ceres Nanosciences is headquartered in Manassas, US.
Which VCs invest in companies like Ceres Nanosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ceres Nanosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ceres Nanosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.